• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Aryl Hydrocarbon Receptor Plays Important Role in Red Cell Development

July 11, 2013

The aryl hydrocarbon receptor (AhR) may play an important physiologicaland functional role in red cell development, according to a new study published in the journal Blood. Using a novel in-vitro serum- and feeder cell-free culture system, researchers showed that functional AhR is expressed in hematopoietic progenitor cells and that activation of AhR resulted in the exponential expansion of these progenitor cells as well as the development of megakaryocyte-and erythroid-lineage cells. Furthermore, modulation of AhR was shown to direct cell fate; chronic AhR agonism favored erythroid differentiation, while acute agonism favored megakaryocyte specification. The study results may potentially allow researchers to generate large quantities of human hematopoietic cells to better understand red cell and platelet development.

Reference

1. Smith, B. W., Rozelle, S. S., Leung, A., Ubellacker, J., Parks, A., Nah, S. K., French D, Gadue P., Monti S., Chui D.H., Steinberg M.H., Frelinger A.L., Michelson A.D., Theberge R., McComb M.E., Costello C.E., Kotton D.N., Mostoslavsky G., Sherr D.H., Murphy, G. J. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood. 2013; doi: 10.1182/blood-2012-11-466722.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Whole Blood Transfusions Early Improve Survival for Trauma Patients

  • HbS Promotes Proinflammatory Cytokine Production in Sickle Cell Disease

  • Benefits and Harms of Whole Blood versus Component Blood Transfusions Remain Unclear

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Pre-Hospital Resuscitation with Low-Titer Type O Whole Blood for Trauma Patients

  • Double-knotting Blood Storage Bag Tubing Reduces Contamination

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley